Company Information

CIN
Status
Date of Incorporation
05 April 1961
Listing Status
Unlisted
State
Delhi
ROC
ROC Delhi
Industry
Pharmaceuticals: Antibiotics, Endocrine Products
Sub Category
Union Govt company
Last Balance Sheet
31 March 2015
Last Annual Meeting
28 August 2015
Paid Up Capital
1,168,833,000
Authorised Capital
1,200,000,000
Financials All Documents available from MCA @Rs 199/-

Directors

Sudhansh Pant
Sudhansh Pant
Director/Designated Partner
over 1 year ago
Manharbhai Valjibhai Zala
Manharbhai Valjibhai Zala
Director/Designated Partner
over 8 years ago

Past Directors

Jaivara Prasad Adithela
Jaivara Prasad Adithela
Director
about 12 years ago
Virender Kumar Mehta
Virender Kumar Mehta
Director
over 12 years ago
Raja Sekhar Vundru
Raja Sekhar Vundru
Director
about 13 years ago
Praveen Kumar
Praveen Kumar
Managing Director
over 13 years ago
Narendra Prasad Gupta
Narendra Prasad Gupta
Nominee Director
over 13 years ago
Asha Rani Rungta
Asha Rani Rungta
Director
about 14 years ago
Devendra Chaudhry
Devendra Chaudhry
Director
about 16 years ago
Jayashree Gupta
Jayashree Gupta
Managing Director
over 18 years ago
Gurdial Singh Sandhu
Gurdial Singh Sandhu
Director
about 20 years ago

Registered Trademarks

Emdopa H Indian Drugs And Pharmaceuticals

[Class : 5] Medicinal And Pharmaceutical Preparations.

Emdopa Plus Indian Drugs And Pharmaceuticals

[Class : 5] Medicinal And Pharmaceutical Preparations.

Hypernol Indian Drugs And Pharmaceuticals

[Class : 5]
View +15 more Brands for Indian Drugs And Pharmaceuticals Limited.

Charges

9 Crore
27 May 2008
State Bank Of India
9 Crore
27 May 2008
State Bank Of India
0
27 May 2008
State Bank Of India
0
27 May 2008
State Bank Of India
0

Documents

Copy of MGT-8-09032018
List of share holders, debenture holders;-09032018
Evidence of cessation;-09032018
Form DIR-12-09032018_signed
Optional Attachment-(1)-09032018
Form MGT-7-09032018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-24032017
Details of comments of CAG if India-24032017
Statement of the fact and reasons for not adopting financial statements in the annual general meeting (AGM)-24032017
Optional Attachment-(1)-24032017
Supplementary or test audit report under section 143-24032017
Form AOC-4(XBRL)-24032017_signed
XBRL document in respect of balance sheet 19012017 for the financial year ending on 31032014
Form 23AC-XBRL-19012017_signed
Annual return as per schedule V of the Companies Act,1956-20122016
Evidence of cessation;-20122016
Optional Attachment-(1)-20122016
Form DIR-12-20122016_signed
Form 20B-20122016_signed
Form DIR-12-06092016_signed
Letter of appointment;-06092016
Optional Attachment-(2)-06092016
Optional Attachment-(3)-06092016
Optional Attachment-(1)-06092016
Declaration of the appointee director, Managing director, in Form No. DIR-2;-06092016
Optional Attachment-(5)-06092016
Optional Attachment-(4)-06092016
Optional Attachment-(1)-05092016
Evidence of cessation;-05092016
Form DIR-12-05092016_signed